Table No.
|
Table Title
|
Table 1.1.1-1
|
Valid registrations of azoxystrobin technical in China, as of 31 Dec. 2013
|
Table 1.1.1-2
|
Valid registrations of azoxystrobin formulations in China, as of 31 Dec. 2013
|
Table 1.1.3-1
|
Basic information of main azoxystrobin technical producers in China, 2013
|
Table 1.1.3-2
|
Capacity and output of azoxystrobin technical producers in China, 2010-2013
|
Table 1.1.3-3
|
Major capacity expansions of azoxystrobin technical in China, 2012-2013
|
Table 1.2.2-1
|
Export situation of azoxystrobin in China, 2013
|
Table 1.2.2-2
|
Export situation of azoxystrobin in China, 2012
|
Table 1.2.2-3
|
Export situation of azoxystrobin in China, 2011
|
Table 1.2.2-4
|
Table exporters of exported azoxystrobin in China, 2013
|
Table 1.2.2-5
|
Table exporters of exported azoxystrobin in China, 2012
|
Table 1.2.2-6
|
Table exporters of exported azoxystrobin in China, 2011
|
Table 1.2.2-7
|
Table Major destinations of exported azoxystrobin in China, 2013
|
Table 1.2.2-8
|
Table Major destinations of exported azoxystrobin in China, 2012
|
Table 1.2.2-9
|
Table Major destinations of exported azoxystrobin in China, 2011
|
Table 1.3.1-1
|
Apparent consumption of azoxystrobin technical in China, 2010-2013, tonne
|
Table 1.3.1-2
|
Consumption volume and value of azoxystrobin formulations in China, 2010-2013
|
Table 1.3.1-3
|
Market value and market share of azoxystrobin formulations, 2010-2013
|
Table 2.1.3-1
|
Major research progress of azoxystrobin technology in China, 2002-2013
|
Table 2.2.2-1
|
Key producers of trimethyl orthoformate in China, 2010-2013
|
Table 6.1-1
|
Contact information of major producers of azoxystrobin in China
|
Table 6.2.1-1
|
Registration situation of azoxistrobin formulations in Argentina, as of Dec. 2013
|
Table 6.2.1-2
|
Registration situation of azoxystrobin formulations in Australia, as of Dec. 2013
|
Table 6.2.1-3
|
Registration situation of azoxystrobin formulations in Austria, as of Dec. 2013
|
Table 6.2.1-4
|
Registration situation of azoxystrobin formulations in Belgium, as of Dec. 2013
|
Table 6.2.1-5
|
Registration situation of azoxistrobin formulations in Brazil, as of Dec. 2013
|
Table 6.2.1-6
|
Registration situation of azoxistrobin formulations in Chile, as of Dec. 2013
|
Table 6.2.1-7
|
Registration situation of azoxystrobin formulations in Greece, as of Dec. 2013
|
Table 6.2.1-8
|
Registration situation of azoxystrobin formulations in India, as of Sept., 2012
|
Table 6.2.1-9
|
Registration situation of azoxystrobin formulations in Netherlands, as of Dec. 2013
|
Table 6.2.1-10
|
Registration situation of azoxystrobin in Paraguay, as of Dec. 2013
|
Table 6.2.1-11
|
Registration situation of azoxystrobin formulations in Singapore, as of Dec. 2013
|
Table 6.2.1-12
|
Registration situation of azoxystrobin formulations in South Africa, as of Dec. 2013
|
Table 6.2.1-13
|
Registration situation of azoxystrobin formulations in Switzerland, as of Dec. 2013
|
Table 6.2.1-14
|
Registration situation of azoxystrobin formulations in Uruguay, as of Dec. 2013
|
Table 6.2.1-15
|
Registration situation of azoxystrobin formulations in Vietnam, as of Sept., 2012
|